Stem cells from human exfoliated deciduous teeth (SHED) are a unique postnatal stem cell population, possessing multipotent differentiation capacity and immunomodulatory properties. However, the mechanism by which SHED treat immune diseases is not fully understood. Here we show that systemic transplantation of SHED via the tail vein ameliorates ovariectomy (OVX)-induced osteopenia by reducing T-helper 1 (Th1) and T-helper 17 (Th17) cell numbers in the recipient OVX mice. Mechanistically, SHED transplantation induces activated T-cell apoptosis in OVX mice via Fas ligand (FasL)-mediated Fas pathway activation, leading to up-regulation of regulatory T-cells (Tregs) and down-regulation of Th1 and Th17 cells. This SHED-mediated immunomodulation rescues OVX-induced impairment of bone marrow mesenchymal stem cells (BMMSCs) and activation of osteoclastogenesis, resulting in increased bone mass. In summary, SHED-mediated T-cell apoptosis via a FasL/Fas pathway results in immune tolerance and ameliorates the osteopenia phenotype in OVX mice.
CenciSWeitzmannMNRoggiaCNambaNNovackDWoodringJ. (2000). Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest106:1229-1237.
4.
CenciSToraldoGWeitzmannMNRoggiaCGaoYQianWP. (2003). Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA100:10405-10410.
5.
ChenCAkiyamaKYamazaTYouYOXuXLiB. (2014). Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression. EMBO Mol Med6:322-334.
6.
ChiangCYKyritsisGGravesDTAmarS (1999). Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun67: 4231-4236.
7.
ChoiHLeeRHBazhanovNOhJYProckopDJ (2011). Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood118:330-338.
8.
CopelanEA (2006). Hematopoietic stem cell transplantation. N Engl J Med354:1813-1826.
9.
DelmasPD (2002). Treatment of postmenopausal osteoporosis. Lancet359:2018-2026.
10.
GaoYGrassiFRyanMRTerauchiMPageKYangX. (2007). IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest117:122-132.
11.
GhannamSPeneJMoquet-TorcyGJorgensenCYsselH (2010). Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol185:302-312.
12.
HildeboltCF (1997). Osteoporosis and oral bone loss. Dentomaxillofac Radiol26:3-15.
13.
HohlbaumAMMoeSMarshak-RothsteinA (2000). Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J Exp Med191:1209-1220.
14.
JeeWSYaoW (2001). Overview: animal models of osteopenia and osteoporosis. J Musculoskel Neuron Interact1:193-207.
15.
KitazawaRKimbleRBVanniceJLKungVTPacificiR (1994). Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest94:2397-2406.
16.
KongYYFeigeUSarosiIBolonBTafuriAMoronyS. (1999). Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature402:304-309.
17.
KotakeSUdagawaNTakahashiNMatsuzakiKItohKIshiyamaS. (1999). IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest109:1345-1352.
18.
KushnerGMAlpertB (2011). Bisphosphonate-related osteonecrosis of the jaws. Curr Opin Otolaryngol Head Neck Surg19:302-306.
19.
LiJYTawfeekHBediBYangXAdamsJGaoKY. (2011). Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci USA108:768-773.
20.
MartinTJRomasEGillespieMT (1998). Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr8:107-123.
21.
MiuraMGronthosSZhaoMLuBFisherLWRobeyPG. (2003). SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A100:5807-5812.
22.
NakamuraTImaiYMatsumotoTSatoSTakeuchiKIgarashiK. (2007). Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell130:811-823.
23.
NautaAJFibbeWE (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood110: 3499-3506.
24.
NemethKLeelahavanichkulAYuenPSMayerBParmeleeADoiK. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med15:42-49.
25.
PluchinoSZanottiLRossiBBrambillaEOttoboniLSalaniG. (2005). Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature436:266-271.
26.
RaiszLG (2005). Pathogenesis of osteoporosis: concepts, conflict, and prospects. J Clin Invest115:3318-3325.
27.
RenGZhangLZhaoXXuGZhangYRobertsAI. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell2:141-150.
28.
RoggiaCGaoYCenciSWeitzmannMNToraldoGIsaiaG. (2001). Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA98:13960-13965.
29.
SatoKSuematsuAOkamotoKYamaguchiAMorishitaYKadonoY. (2006). Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med203:2673-2682.
30.
SchettGDavidJP (2010). The multiple faces of autoimmune mediated bone loss. Nat Rev Endocrinol6:698-706.
TakayanagiHOgasawaraKHidaSChibaTMurataSSatoK. (2000). T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-gamma. Nature408:600-605.
33.
UccelliAMorettaLPistoiaV (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol8:726-736.
34.
WangLZhaoYLiuYAkiyamaKChenCQuC. (2013). IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling. Stem Cells31:1383-95.
35.
WeitzmannMNPacificiR (2006). Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest116:1186-1194.
36.
WeitzmannMNCenciSRifasLHaugJDipersioJPacificiR. (2001). T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand dependent and independent mechanisms. J Bone Miner Res16:328-337.
37.
YamazaTMiuraYBiYLiuYAkiyamaKSonoyamaW. (2008). Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One3:e2615.
38.
YamazaTKentaroAChenCLiuYShiYGronthosS. (2010). Immunomodulatory properties of stem cells from human exfoliated deciduous teeth. Stem Cell Res Ther1:5.
39.
ZhangYXuGZhangLRobertsAIShiY (2008). Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma. J Immunol181:190-196.
40.
ZhengYLiuYZhangCMZhangHYLiWHShiS. (2009). Stem cells from deciduous tooth repair mandibular defect in swine. J Dent Res88:249-254.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
